GE Healthcare Launches New Breast Health Portfolio

0
280

Mammograms are a critical tool in detecting breast cancer, yet one in four women avoid the exam because of discomfort and fear and anxiety from the potential result of the exam.

The choice to skip a mammogram can delay a breast cancer diagnosis and impact a patient’s long-term prognosis.

GE Healthcare is committed to developing solutions for women that encourage adherence to screening guidelines, improve outcomes for breast cancer screening and give women an opportunity to be active participants in their health care.

That’s why a team of women used their unique insights, coupled with feedback from patients, technologists and radiologists, to design a new mammography system, the Senographe Pristina. The system offers patients the option to use Pristina Dueta, a newly FDA cleared industry-first patient-assisted compression device, which literally puts women in control of their mammograms. In traditional mammography, the technologist performing the exam compresses the patient’s breast, often causing discomfort. Pristina Dueta allows women to control the application of compression to minimize the perceived pain and discomfort often associated with a mammogram with the help of a technologist. After the breast is properly positioned by the technologist, the patient can use a handheld wireless remote control to adjust the compression based on the patient’s comfort level.

The Senographe Pristina also has the same high image quality and low dose – the lowest dose of all 3D FDA-approved systems – customers and patients have come to expect, and new comfort features that help decrease pain and reduce anxiety associated with the exam. It replaces traditional design with rounded edges and a thinner image detector to create a more pleasant experience for women as well as armrests that position women to relax rather than tense up during the compression and image acquisition process.

Senographe Pristina uses Seno Iris, a powerful and highly scalable workstation designed to speed up mammography diagnoses. Its Enhanced V-Preview image option shows 92 percent of all masses so the radiologist can spend less time scrolling through volume to detect suspicious areas. Once a suspicious area is found on Enhanced V-Preview, the Seno Iris navigation tools allow the radiologist to navigate in tomosynthesis volume quickly to the location of the suspicious area. Radiologists can read tomosynthesis cases 29 percent faster using enhanced V-Preview and Seno Iris navigation tools compared to not using these tools.

Radiologists can also now take Senographe Pristina directly to their patients with a novel configuration: a fully-equipped road-ready Senographe Pristina mobile unit.
GE Healthcare also recently introduced SenoBright HD, a next-generation Contrast Enhanced Spectral Mammography (CESM) exam designed to aid health care providers in breast cancer diagnosis by delivering clear images for a confident and fast patient diagnosis and overall improved patient experience.

Senographe Crystal Nova is a new, more affordable performance digital mammography offering that uses the same carbon fiber image detector as the Senographe Pristina.
Health care providers have the option to incorporate the Senographe Pristina, Senographe Crystal Nova and the accessories in a SensorySuite – a room designed to reduce a patient’s anxiety, discomfort and pain during a mammogram by simultaneously stimulating three of a woman’s senses: scent, sight and sound.

LEAVE A REPLY

Please enter your comment!
Please enter your name here